cure of hypertension after surgical revascularization was followed with enthusiasm for renal artery repair. 1 When surgery was applied indiscriminately, however, the surgical correction of ASO-RVD was associated with a beneficial blood pressure response in less than half of the patients who underwent operation. 2,3 These surgical results fostered pessimism regarding the value of the operative repair of ASO-RVD for the treatment of hypertension. Moreover, this pessimism was strengthened with the introduction of new antihypertensive agents that provided medical control of even severe hypertension. When applied to renovascular hypertension associated with global renal artery disease, however, these new agents occasionally precipitated a second pathologic sequelae of ASO-RVD-renovascular renal insufficiency or ischemic nephropathy. 4 As the recognized pathologic sequelae of ASO-RVD changed, the options for renal artery intervention also changed. Percutaneous transluminal renal artery angioplasty During the past 50 years, indications and methods for the treatment of atherosclerotic renovascular disease (ASO-RVD) have changed. In 1954, the first reported 
cure of hypertension after surgical revascularization was followed with enthusiasm for renal artery repair. 1 When surgery was applied indiscriminately, however, the surgical correction of ASO-RVD was associated with a beneficial blood pressure response in less than half of the patients who underwent operation. 2, 3 These surgical results fostered pessimism regarding the value of the operative repair of ASO-RVD for the treatment of hypertension. Moreover, this pessimism was strengthened with the introduction of new antihypertensive agents that provided medical control of even severe hypertension. When applied to renovascular hypertension associated with global renal artery disease, however, these new agents occasionally precipitated a second pathologic sequelae of ASO-RVD-renovascular renal insufficiency or ischemic nephropathy. 4 As the recognized pathologic sequelae of ASO-RVD changed, the options for renal artery intervention also changed. Percutaneous transluminal renal artery angioplasty During the past 50 years, indications and methods for the treatment of atherosclerotic renovascular disease (ASO-RVD) have changed. In 1954, the first reported (PTRA) was introduced in 1978 and was followed a decade later with the application of intraluminal stents. 5, 6 On the basis of high rates of immediate technical success and low rates of procedural morbidity, PTRA was adopted as the preferred treatment of ASO-RVD in many centers. However, recently published prospective randomized trials that compared medical management and PTRA with or without endoluminal stents for ASO-RVD have questioned the advantage of PTRA over medical management alone. [7] [8] [9] Throughout these periods of change, little attention has been given to the management of ASO-RVD as it relates to the clinical outcome of primary importance: survival free of dialysis-dependence. From our clinical experience, we have reported on this outcome for several patient subgroups. [10] [11] [12] [13] [14] [15] [16] This retrospective review examines our center's cumulative operative experience with ASO-RVD in consecutive adults with hypertension who underwent treatment during a recent 12-year period. The specific points of interest included: 1, preoperative predictors of dialysis-free survival; 2, blood pressure and renal function response to operation; and 3, relationship between blood pressure and renal function response to operation and survival free of dialysis-dependence.
PATIENTS AND METHODS

Patient population. Between January 1987 and
December 1999, 626 patients underwent surgical repair of renal artery disease at Wake Forest University School of Medicine. Five hundred patients with hypertension were considered to have symptomatic ASO-RVD. These patients form the basis of this report. The patients who were omitted from review included those with fibromuscular dysplasia, renal artery aneurysm and dissection, emergency operations for the treatment of complications of PTRA, congenital renal artery hypoplasia, and arteritis.
The criteria for operative intervention for patients with ASO-RVD included severe or uncontrolled hypertension with or without excretory renal insufficiency and hemodynamically significant renal artery stenosis or occlusion. This subgroup included 254 women and 246 men who ranged in age from 34 to 88 years (mean age, 65 ± 9 years). Severe or uncontrolled hypertension was present in all of the patients (mean blood pressure, 200 ± 35/104 ± 21 mm Hg; mean number of medications, 2.6 ± 1.1) and ranged in duration from 1 month to 57 years (mean, 10.0 ± 9.1 years). The preoperative mean and median serum creatinine levels were 2.6 mg/dL and 1.7 mg/dL, respectively, with a mean estimated glomerular filtration rate (EGFR) of 40.5 ± 23.2 mL/min/m 2 . Two hundred forty-four patients had a preoperative serum creatinine level of 1.8 mg/dL or more and were considered to have ischemic nephropathy. Significant extra-renal atherosclerosis was present in 451 patients (90%) at the time of operation (Table I) , and 78 patients (16%) had diabetes mellitus.
Patient evaluation. In addition to complete history and physical examination, further cardiac evaluation included resting or stress echocardiography (458 patients; JOURNAL OF VASCULAR SURGERY Volume 35, Number 2 Cherr et al 237 91%), stress electrocardiography (187 patients; 37%), or cardiac catheterization (87 patients; 17%). The ejection fraction ranged from 25% to 70% (mean, 59% ± 7.7%). Preoperative cardiac evaluation resulted in 22 coronary interventions (14 percutaneous transluminal coronary interventions and eight coronary artery bypass grafts) before renal artery repair.
Angiography results showed significant (≥80% ostial stenosis or occlusion) unilateral renal artery disease in 203 patients (41%) and bilateral disease in 297 patients (59%), including 21 patients with significant disease to a solitary kidney. One hundred sixty-four renal artery occlusions were present in 155 patients. One hundred thirty-one patients (26%) had abdominal aortic aneurysms, and 254 patients (51%) had severe aortic occlusive disease (occlusion or >60% stenosis of the common or external iliac arteries or distal aorta).
Operative management. Two hundred three patients (41%) had clinically significant unilateral renal artery disease, and 297 (59%) had global renal artery disease (276 patients with bilateral disease and 21 patients with disease to a solitary kidney). The methods of operative repair are described in Table II . Renal revascularization combined with aortic or mesenteric reconstruction was performed in 205 patients (41%). Seventy-six patients underwent combined repair of clinically significant aortic occlusive disease, and 57 patients underwent repair of abdominal aortic aneurysm. Sixty-three patients underwent combined repair of both aortic occlusive disease and aneurysmal disease.
Response to surgery and follow-up examination data. Blood pressure response was determined from blood pressure measurements at 8 weeks or more after surgery according to previously published criteria. 12 Renal function response was determined from EGFR estimated from serum creatinine levels measured at 3 weeks or more after surgery. A 20% or more increase in EGFR or removal from dialysis-dependence was considered improved renal function, and a 20% or more decrease in EGFR was considered worsened function. All other responses were defined as no change.
Follow-up cardiovascular events, mortality rates, and causes of death were obtained from a vascular surgery database, medical records, and telephone interviews. The mortality data were supplemented with a National Death Index search.
Statistical methods and analysis. To account for between-subject differences in sex, age, and weight, EGFR (mL/min/m 2 ) was calculated with the formula of Cockroft and Gault as modified by Rolin, Hall, and Wei. 17 Descriptive statistics for factors of interest were computed for all the patients. Paired t tests were used for the assessment of preoperative to postoperative within-group changes, and χ 2 tests were used for the comparison of renal function response to operation with preoperative levels of renal function. Follow-up outcomes included time to death (all causes), time to cardiovascular death, and time to death or dialysis (whichever occurred first). Survival and dialysis-free survival rates were depicted graphically with Kaplan-Meier method product-limit estimates. 18 Associations between selected preoperative and postoperative variables and outcome were assessed with multivariate Cox proportional hazards models. 19 Preoperative variables in the model included the following clinical parameters listed in Table I : age, race, gender, EGFR, systolic and diastolic blood pressure, number of antihypertensive medications, extent of renal repair (unilateral or bilateral), and combined aortorenal repair. Postoperative variables included EGFR response, hypertension response, systolic and diastolic blood pressure, and number of antihypertensive medications. Separate "best" models were selected for each outcome with a backwards stepwise elimination technique in which all factors of interest were included in the first step and factors that were not significant at the .10 alpha level were eliminated one by one until all factors that remained in the model were significant at the .10 level. 19 
RESULTS
Perioperative morbidity and mortality rates. Twentythree patients (4.6%) died in the hospital or within 30 days of JOURNAL OF VASCULAR SURGERY 238 Cherr et al February 2002 surgery. All but one death occurred after bilateral renal artery reconstruction or renal reconstruction combined with simultaneous aortic or mesenteric artery repair. Mortality rates after isolated renal artery repair (0.8%) differed significantly from the rates for combined aortic and bilateral repair (6.9%; P = .0125). However, perioperative mortality rates showed significant and independent associations with only advanced age (P < .0001; hazard ratio, 3.25; 95% confidence interval [CI], 1.85 to 5.70) and clinical congestive heart failure (P = .013; hazard ratio, 3.05; 95% CI, 1.26 to 7.34).
Perioperative morbidity (excluding perioperative deaths) occurred in 81 patients (16%). These events included myocardial infarction (15 patients), stroke (five patients), significant arrhythmia (22 patients), and pneumonia (36 patients). Five patients had worsening renal function after operation that resulted in permanent dialysis-dependence within 1 month of surgery. The mean preoperative serum creatinine levels and EGFR for these five patients were 3.4 mg/dL and 20.2 mL/min/m 2 . Nine patients who were undergoing dialysis before renal revascularization continued to need renal replacement therapy after operation.
Late mortality and cardiovascular morbidity rates. Follow-up data were available for 99% of the patients who survived surgery. During the follow-up examination period (mean, 56 months; range, 1 to 159 months), there were 171 deaths with estimated 5-year and 10-year survival rates for all the patients of 69.0% and 33.6%, respectively. Product limits of time to death or dialysis are depicted in Fig 1. Cardiovascular events accounted for most (74%) of the late deaths, including coronary artery disease (41%) and stroke (9%). Of the late deaths, 24% occurred from the treatment of or complications from aneurysmal disease or noncoronary atherosclerosis. Other causes of death included cancer (12%), lung disease (6%), and other causes (8%). Of the patients who died during the follow-up examination period, 38% needed renal replacement therapy before death. factors that were significantly and independently associated with increased risk of death from all causes included poor preoperative renal function, diabetes mellitus, history of myocardial infarction or stroke, severe aortic occlusive disease, increased age, and renal function worsened after operation. Prior myocardial revascularization, blood pressure cured, and increased systolic blood pressure favored survival. These associations were significant and independent of other parameters. Two hundred eighteen nonfatal cardiovascular events occurred in 139 patients (28%). These events included angina (49 patients), myocardial infarction (29 patients), percutaneous transluminal coronary angioplasty (19 patients), and coronary artery bypass grafting (22 patients). Cerebrovascular events included transient ischemic attacks (18 patients), stroke (22 patients), and carotid endarterectomy (27 patients). Lower extremity revascularization was necessary in 11 patients. Other vascular reconstructions included aortomesenteric reconstruction (five patients), thoracoabdominal aortic aneurysm repair (seven patients), and renal revascularization for progression of contralateral ASO-RVD (12 patients). With multivariate analysis results, only preoperative angina (P = .001; odds ratio [OR], 2.18; 95% CI, 1.25 to 3.84) showed a significant and independent association with late cardiovascular morbidity rate. Neither blood pressure nor renal function response showed an association with follow-up cardiovascular morbidity rate. However, vascular reconstruction during the follow-up examination period was predicted with male gender (P = .009; OR, 2.10; 95% CI, 1.21 to 3.67) and combined aortorenal repair (P = .008; OR, 2.36; 95% CI, 1.26 to 4.46).
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Eighty-four patients eventually became dialysis-dependent during the follow-up examination period. Of the 84 patients who became dialysis-dependent, 65 patients (77%) died during the follow-up period. Causes of death in patients who needed renal replacement therapy included coronary artery disease (39%), noncoronary atherosclerosis (37%), stroke (9%), cancer (7%), lung disease (4%), and other causes (4%). Fig 2 depicts the estimated survival rate for patients after the initiation of renal replacement therapy. The median survival rate after dialysis-dependence was 18.6 months, with 27% of the patients alive at 5 years. Ten patients who became dialysis-dependent had anatomic failure of 13 renal artery repairs as defined with renal duplex scanning.
Overall, 389 patients underwent 1295 intraoperative and postoperative renal duplex sonographic scan evaluations of 622 renal artery repairs. Intraoperative revision of major B-scan defects was necessary in 7.1% of the repairs. Restenosis or thrombosis of 24 renal artery repairs (3.9%) occurred in 20 patients (5.0%) who underwent evaluation with postoperative duplex scanning.
Blood pressure response. Of the 477 patients who survived surgical repair, 12% were considered cured, 73% had improved blood pressure, and 15% had failed hypertension response. The preoperative and postoperative blood pressure and medication requirements for each group are listed in Table IV . In comparison with blood pressure improved or failed, blood pressure cured was significantly and independently associated with improved dialysis-free survival rate (P = .011; OR, 0.52; 95% CI, 0.30 to 0.88). Although improved blood pressure was associated with significant postoperative decreases in blood pressure and medication requirements (blood pres- sure, 205/107 versus 147/81 mm Hg; P < .0001; medications, 2.8 versus 1.7; P < .0001), these differences were not associated with increased dialysis-free survival rate.
The product-limit estimates of dialysis-free survival rate according to postoperative blood pressure response are depicted in Fig 3. Renal function response. In all the patients who survived surgery, there was a significant increase in postoperative EGFR as compared with preoperative EGFR (preoperative EGFR, 41.1 ± 23.9 mL/min/m 2 , versus postoperative EGFR, 48.2 ± 25.5 mL/min/m 2 ; P < .0001). Among individual patients, 43% had improved renal function, 47% were considered unchanged, and 10% were worsened after surgical repair. Twenty-eight patients (70%) who needed renal replacement therapy before operation were permanently removed from dialysis after surgery.
As preoperative serum creatinine levels increased or renal function progressed to dialysis-dependence, a greater proportion of patients had improved postoperative renal function (Table V) . This association between increased preoperative serum creatinine levels and improved postoperative renal function was significant (P < .0001). February 2002 Death or dialysis showed significant associations with both preoperative parameters and postoperative blood pressure and renal function response. Table VI summarizes the proportional hazards regression analysis results for time to death or dialysis during the follow-up examination period. Preoperative factors that were significantly and independently associated with death or dialysis included diabetes mellitus, severe aortic occlusive disease, poor renal function, and high preoperative systolic blood pressure. Significant and independent associations were noted for blood pressure cured as compared with blood pressure improved or worsened. Moreover, improved postoperative renal function showed significant and independent associations with increased dialysis-free survival rate as compared with renal function unchanged. The relationship between each category of renal function response and dialysis-free survival rate showed significant interactions with preoperative renal function. For patients with renal function unchanged, an increased risk of death or dialysis was observed for patients with poor preoperative renal function. For patients whose renal function worsened, an increased risk of death or dialysis was significant 
DISCUSSION
This review of our center's cumulative experience during the past 12 years was undertaken to describe the relationship between the results of operative intervention for ASO-RVD and the clinical outcome of primary importance: survival free of dialysis-dependence. Each patient had significant preoperative hypertension, 90% of the patients had extrarenal atherosclerosis, and 49% had a preoperative serum creatinine level of 1.8 mg/dL or more, including 40 patients who were dependent on dialysis before operation. Advanced age and clinical congestive heart failure predicted the 4.6% perioperative mortality rate, with 22 of 23 deaths occurring after bilateral renal artery repair or renal artery repair combined with aortic or visceral artery reconstruction. Although a beneficial blood pressure response was observed in 85% of the patients who survived surgery, only patients who were cured of hypertension showed a significant and independent increase in dialysis-free survival rate. A similar benefit was not observed for the patients considered improved but who continued to need antihypertensive medication for blood pressure control. Moreover, renal function response showed a significant and independent association with dialysis-free survival rate. Among the patients with preoperative renal dysfunction, those who achieved at least a 20% increase in EGFR had improved rates of survival free of dialysis-dependence.
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Although we believe that this review provides useful information regarding the clinical response after operative repair of ASO-RVD and its relationship with dialysis-free survival, the lack of a randomly selected, medically managed group for comparison limits the value of these observations. Currently, there are no prospective, randomized studies that compare surgical and medical management of ASO-RVD. However, three recently published studies compared PTRA and medical management. [7] [8] [9] Although PTRA is widely applied as a primary intervention for ASO-RVD, each of these prospective, randomized trials concluded that PTRA provided no blood pressure benefit over medical management alone. The largest of these trials randomized 106 patients with hypertension with ASO-RVD to medical management or PTRA between 1993 and 1998. 9 The trial results showed no significant difference between PTRA and medical treatment groups when mean blood pressure or serum creatinine levels were considered. Moreover, a 43% rate of renal artery restenosis was observed among the PTRA group. On the basis of these findings, the authors concluded that, in patients with ASO-RVD and hypertension, PTRA had little advantage over medical therapy. Despite an excellent overall study design, the conclusions offered by these authors have been criticized because of low rates of patient recruitment per center, failure to measure pressure gradients before and after PTRA, limited use of endoluminal stents, and crossover from medical management to PTRA. Despite these potential limitations, two smaller prospective, ran-JOURNAL OF VASCULAR SURGERY 242 Cherr et al February 2002 domized trials have arrived at similar conclusions. 7, 8 Unfortunately, none of these studies describe individual renal function response to PTRA, provide long-term clinical follow-up examination, or relate clinical response to survival free of dialysis-dependence. [7] [8] [9] A single prospective, randomized study has compared PTRA and surgical repair of ASO-RVD. 20 Weibull and colleagues 20 randomly assigned patients who were less than 70 years old without diabetes, with hypertension, and with unilateral renal artery stenosis to either PTRA or surgical repair. The hypothesis proposed by these authors was that PTRA should be considered the initial intervention of choice if the technical success rate was 80% or more with a 2-year primary patency rate of 75% or more and blood pressure and renal function response were equivalent to those of surgical repair. Although these investigators did not examine dialysis-free survival rate, the study design showed several strengths. Renovascular hypertension was defined with renal vein renin assays, glomerular filtration rate was measured with Cr-EDTA clearance, and serial angiographic follow-up examination was performed for all patients. Primary and secondary patency rate was observed in 75% and 90% of patients after PTRA and 96% and 97% of patients after surgery. Hypertension was cured or improved in 83% of the PTRA group and in 89% after surgical repair. Although renal function was significantly worse in the randomly selected surgical group, neither treatment group showed change in renal function after intervention. On the basis of these results, the authors recommended PTRA as the first intervention for unilateral ASO-RVD that causes renovascular hypertension. 20 Criticisms of this clinical trial included stringent patient selection criteria that created a patient cohort not representative of most patients with ASO-RVD, significant differences in baseline renal function between the two treatment groups, and crossover from PTRA to surgical therapy after PTRA failure. In this latter regard, however, endoluminal stents were not used in conjunction with PTRA in either primary or secondary fashion. Hypertension response has been the primary outcome measure for the vast majority of intervention studies for ASO-RVD. Because the relationship between adverse cardiovascular events and blood pressure has long been considered quantitative, the lack of association between improved blood pressure response and cardiovascular morbidity or mortality rate was an unexpected finding. In the absence of validating studies, this observation may reflect limitations in our grading system for blood pressure response. Blood pressure response was categorized to account for both magnitude change in diastolic pressure and change in the number of antihypertensive medications, but neither change in systolic pressure nor change in class or dose of antihypertensive medication was considered. However, when the changes in systolic, diastolic, and pulse pressures were considered as continuous variables, no significant associations between improved blood pressure response and morbidity or mortality rate were noted. For patients whose conditions were considered improved, the observed decrease in mean systolic and diastolic blood pressure of 58 and 26 mm Hg, respectively, showed no apparent association with cardiovascular morbidity, death from all causes, or cardiovascular death. These results suggest that the quantitative association between blood pressure and survival rate observed in population-based studies may not apply to the current patient group characterized with ASO-RVD. In this latter regard, the presence of ASO-RVD in combination with diffuse atherosclerosis and renal insufficiency may limit the survival benefit conferred with improved blood pressure control in all but those patients cured of hypertension.
In addition to this report, we have recently described the event-free survival rate after operative treatment for ASO-RVD in the subgroup of patients with ischemic nephropathy. 16 Among the patients with preoperative serum creatinine levels of 1.8 mg/dL or more, preoperative EGFR and renal function response to operation were the strongest predictors of dialysis-free survival rate. As compared with the patients with renal function unchanged or worsened, only the patients with improved renal func-JOURNAL OF VASCULAR SURGERY Volume 35, Number 2 Cherr et al 243 tion after operation showed increased rate of survival free from dialysis-dependence. These same relationships exist in this report for the entire patient group with ASO-RVD. However, they are strongest for the patients with poor preoperative excretory renal function. Moreover, when all the patients with ASO-RVD were considered, increased severity of preoperative hypertension was associated with improved dialysis-free survival rate. This observation suggests a possible change in the pathologic sequelae of importance in ASO-RVD. In this shifted paradigm, severe hypertension could be viewed as the key preoperative characteristic that favored clinical benefit, and renal function after operation could be considered the key response-the primary determinant of dialysis-free survival. Viewed in this way, future trials that examine the best method of management of ASO-RVD should consider early renal function response as a primary endpoint.
Once ASO-RVD is identified in combination with severe hypertension and excretory renal insufficiency, discriminating predictors of cured blood pressure or improved renal function are lacking. Results from renal vein systemic renin index have been proposed to predict hypertension cure. 21 Although we advocate the use of renal vein renin assays to guide management in selected cases of unilateral renal artery disease, whether considered as index or ratio values, lateralizing renin assays have predicted blood pressure benefit but not cure. 10 Similarly, renal function response in patients with ASO-RVD is uncertain after renal artery intervention. 16 Recent studies have described significant correlation between parameters derived from renal parenchymal Doppler scan spectral analysis and response to intervention. 22, 23 Despite extensive experience with these techniques, we have not been able to reproduce these results at our center. In our clinical experience, the factors that favor the recovery of renal function after operation have included severe preoperative hypertension, bilateral or global ASO-RVD as the result of high-grade (>95%) stenosis, or renal artery occlusion and rapidly deteriorating renal function. [10] [11] [12] 15, 16 When these features were expressed in their most extreme forms as dialysis-dependent ischemic nephropathy, 70% of the patients who underwent operation were removed from dialysis-dependence. Given the impact of renal function on both the quality and the quantity of life, the definition of predictors of function response after renal artery intervention is an imperative for future investigation.
In addition to limitations imposed by the lack of a randomly selected, medically managed group for comparison, the selection criteria and operative strategies used for patients in this report introduced significant bias. First, hypertension was considered a prerequisite for operative intervention for ASO-RVD. Empirical repair in the absence of renin assays or when renin assays were negative was reserved for patients with severe hypertension, especially when hypertension was present in combination with renal insufficiency. As a result, the hypertension for the group was severe and the mean EGFR was reduced for age. Secondly, previous experience has shown that the greatest incremental increase in EGFR resulted from the repair of all hemodynamically significant renal artery disease. 4, 10, 16 Consequently, 59% of the patients had bilateral renal artery reconstruction and all significant disease was repaired at a single operation. In keeping with the objective of maximum recovery of excretory renal function, nephrectomy was reserved for a nonfunctioning kidney with an unreconstructable renal artery, without regard to arbitrary parameters of renal length. As a result, only 53 nephrectomies were performed in this patient group, although 164 renal artery occlusions were present. Finally, the patients with advanced renal dysfunction (ie, serum creatinine level of ≥3.0 mg/dL) were selected for operative intervention on the basis of the presence of severe hypertension and global ASO-RVD in combination with rapidly deteriorating renal function. With these selection criteria, the proportion of patients with improved postoperative renal function increased with increasing preoperative serum creatinine level.
In summary, surgical repair of ASO-RVD can improve blood pressure control and renal function in selected patients with severe hypertension. Early response to surgical intervention influenced dialysis-free survival rate.
Patients with blood pressure cure showed increased dialysis-free survival rate as compared with patients with improved or unchanged blood pressure. For patients with poor preoperative renal function, improved postoperative renal function was associated with increased dialysis-free survival rate when compared with patients with unchanged renal function. These results emphasize the need for strategies to predict the response to renal artery intervention and support a prospective, randomized clinical trial that would compare medical management, PTRA, and surgical renal artery repair to define the optimal method of intervention for patients with ASO-RVD.
